Last month, the National Institute of Neurological Disorders and Stroke stopped one of the largest clinical trials for Parkinson’s disease to date. This trial was investigating whether a nutritional supplement, creatine, might have potential to treat Parkinson’s disease.
Last month, PDF hosted a special screening of the film, A Late Quartet in New York, NY, followed by a conversation with its Director, Yaron Zilberman, PDF Scientific Director Dr. Stanley Fahn and PDF Research Advocate Pam Quinn. If you haven’t yet heard of this film, which is produced by Entertainment One Films, it stars Philip Seymour Hoffman, Catherine Keener, Mark Ivanir and Christopher Walken as a string quartet struggling to stay together in the face of competing egos and … Parkinson’s disease. As you too often tell us, your neighbors and friends may not truly understand the disease. So… Read More
Will eating berries lessen your risk of Parkinson’s? What about coffee? What’s the real story on coconut oil? Is deep brain stimulation a miracle surgery? All of us, whether or not we live Parkinson’s, are faced each day with a barrage of headlines about what might help or harm our health. After such headlines appear, PDF often receives an influx of inquiries asking: Does this new drug/therapy/compound help Parkinson’s? Is this new drug a cure? When will this new breakthrough be available? The Good News Scientists all over the world are conducting research into Parkinson’s. They are publishing their work… Read More
Are you a runner looking for your next big race? Interested in completed a 26.2 to support Parkinson’s disease research? Well, you are in luck! PDF has six valuable entries into the 2012 Marine Corps Marathon on Sunday, day, October 28 in Arlington, VA! To make you aware of just how valuable these six entries are … last week’s registration marked the fastest sellout in the history of marathon events, the Marine Corps Marathon sold out 30,000 available online entries in 2 hours, 41 minutes, beating the previous registration record of eight hours for the 2011 Boston Marathon. So, the… Read More
From James Beck, Ph.D., Director of Research Programs Understanding how Parkinson’s disease starts and how it progresses remain two of the key unanswered questions about the disease. This is why a recent story in the New York Times caught my eye. The article described how two independent groups of scientists found evidence that Alzheimer’s disease may spread from brain cell to brain cell much like a virus. These scientists engineered mice to make a human form of a protein called tau in only one small part of the brain. Clumps of the tau protein are a hallmark of Alzheimer’s disease…. Read More